Recent advances in the pharmacotherapy for hyperbilirubinaemia in the neonate.
about
Hyperbilirubinemia in Neonates: Types, Causes, Clinical Examinations, Preventive Measures and Treatments: A Narrative Review ArticleTargeted suppression of heme oxygenase-1 by small interference RNAs inhibits the production of bilirubin in neonatal rat with hyperbilirubinemia.Impact of probiotics on the course of indirect hyperbilirubinemia and phototherapy duration in very low birth weight infants.
P2860
Recent advances in the pharmacotherapy for hyperbilirubinaemia in the neonate.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Recent advances in the pharmacotherapy for hyperbilirubinaemia in the neonate.
@ast
Recent advances in the pharmacotherapy for hyperbilirubinaemia in the neonate.
@en
type
label
Recent advances in the pharmacotherapy for hyperbilirubinaemia in the neonate.
@ast
Recent advances in the pharmacotherapy for hyperbilirubinaemia in the neonate.
@en
prefLabel
Recent advances in the pharmacotherapy for hyperbilirubinaemia in the neonate.
@ast
Recent advances in the pharmacotherapy for hyperbilirubinaemia in the neonate.
@en
P2860
P1476
Recent advances in the pharmacotherapy for hyperbilirubinaemia in the neonate.
@en
P2093
Thor Willy Ruud Hansen
P2860
P304
P356
10.1517/14656566.4.11.1939
P407
P577
2003-11-01T00:00:00Z